RALEIGH, N.C., Sept 17 (Bernama-GLOBE NEWSWIRE) — PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective September 14, 2020.
“We are delighted that Glen will be joining our Board of Directors. With his widespread involvement in the healthcare field as both a physician and an executive, Dr. Stettin’s experience in innovation, data, analytics, technology and integrated health solutions will provide the Board with valuable insight as we continue to reinvent clinical research and make it more accessible to patients,” said Colin Shannon, President, Chief Executive Officer and Chairman of the Board of Directors of PRA Health Sciences, Inc.
